首页> 外文OA文献 >P248 Subcutaneous secukinumab 150 mg provides rapid and sustained relief in total and nocturnal back pain, morning stiffness and fatigue in patients with active AS over 4 years

【2h】

P248 Subcutaneous secukinumab 150 mg provides rapid and sustained relief in total and nocturnal back pain, morning stiffness and fatigue in patients with active AS over 4 years

机译：P248皮下Secukinumab 150mg为总有效和夜间背部疼痛，早晨僵硬和疲劳提供快速和持续缓解，患者患者有超过4年

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Helena Marzo-Ortega; Corinne Miceli-Richard; Sonja Gill; Marina Magery; Paula G. P Machado; Abhijit Shete; Jianyuan Wang; Susanne Rohrer; Atul Deodhar;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Secukinumab provides rapid and persistent relief in pain and fatigue symptoms in patients with ankylosing spondylitis irrespective of baseline C-reactive protein levels or prior tumour necrosis factor inhibitor therapy: 2-year data from the MEASURE 2 study [J] . Deodhar A., Conaghan P. G., Kvien T. K., Clinical and experimental rheumatology . 2019,第2期

机译：Secukinumab在带状肌脊柱炎患者的疼痛和疲劳症状中提供快速且持续的缓解，无论基线C反应蛋白水平还是先前的肿瘤坏死因子抑制剂治疗：2年来自措施2研究
2. Secukinumab provides rapid and sustained pain relief in psoriatic arthritis over 2?years: results from the FUTURE 2 study [J] . Iain B. McInnes, Philip J. Mease, Georg Schett, Arthritis research & therapy. . 2018,第1期

机译：Secukinumab在银屑病关节炎中持续2年以上可提供快速且持续的疼痛缓解：《未来2》研究的结果
3. SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE ANKYLOSING SPONDYLITIS: 2-YEAR RESULTS FROM A PHASE 3 TRIAL WITH SUBCUTANEOUS LOADING AND MAINTENANCE DOSING (MEASURE-2) [J] . Marzo-Ortega H., Legerton C. W., Sieper J., Clinical and experimental rheumatology . 2016,第4期

机译：SECUKINUMAB在主动性强直性脊柱炎的体征和症状中提供了持续的改善：来自第3阶段试验的两年结果，该试验具有连续的负荷和维持剂量（措施2）
4. Part I. Hz166, a novel γ-aminobutyric acid (A) receptor subtype-selective ligand active against neuropathic pain Part II. The first enantiospecific, stereospecific total synthesis of the C-19 methyl substituted sarpagine indole alkaloids 19(S), 20(R), 19-(S),20(R)dihydroperaksine-17-al and peraksine Part III. Application of metal-carbenoid chemistry and Brönsted acid mediated cyclization of enaminones for the rapid and efficient access to the tetracyclic (ABCE) skeleton of the Strychnos alkaloids contained in bisindole alkaloids [D] . Edwankar, Rahul V. 2010

机译：第I部分：Hz166，一种新型的对神经性疼痛有活性的γ-氨基丁酸（A）受体亚型选择性配体。 C-19甲基取代的沙雷帕金吲哚生物碱19（S），20（R），19-（S），20（R）dihydroperaksine-17-al和peraksine第三部分的第一个对映体特异性，立体定向全合成。金属类固醇化学和布朗斯台德酸介导的烯胺酮环化的应用，用于快速有效地获取双吲哚生物碱中马兜铃生物碱的四环（ABCE）骨架
5. Secukinumab provides rapid and sustained pain relief in psoriatic arthritis over 2 years: results from the FUTURE 2 study [O] . Iain B. McInnes, Philip J. Mease, Georg Schett, 2018

机译：Secukinumab可以在2年内快速持续缓解银屑病性关节炎：未来2研究的结果
6. Secukinumab 150/300 mg Provides Sustained Improvements in the Signs and Symptoms of Active Ankylosing Spondylitis: 3‐Year Results from the Phase 3 MEASURE 3 Study [O] . Karel Pavelka, Alan J. Kivitz, Eva Dokoupilova, 2020

机译：Secukinumab 150/300mg提供了活性强直性脊柱炎的迹象和症状的持续改进：3年度的3年结果3次研究

P248 Subcutaneous secukinumab 150 mg provides rapid and sustained relief in total and nocturnal back pain, morning stiffness and fatigue in patients with active AS over 4 years

著录项

相似文献

相关主题

期刊订阅